Increasing use of immune checkpoint inhibitors (ICIs) for the treatment of cancer with has led to an increasing incidence of immune related adverse events (irAEs). Cutaneous toxicities are some of the most common irAE manifestations, but clinicians may be less trained to recognize signs and symptoms in non-White patients. Social determinants of health that may impact a patient s ability to receive recommended treatment for irAEs include geographic location, transportation difficulties, low income, and language barriers. Implicit and explicit biases may impact a patient s ability to receive guideline-recommended care from healthcare team members. Focused efforts are needed to address health care inequities in patients being treated with ICIs and to improve chances of achieving the best possible outcomes for all patients. Clinicians need to incorporate considerations for health care disparities into care planning to effectively manage irAEs in historically disadvantaged patient populations. In this CMEO BriefCase, expert faculty will present information on how healthcare disparities impact irAE recognition and management and pharmacist considerations for social determinants of health relative to irAE diagnosis and treatment planning. Discussion will include strategies for addressing healthcare inequities in order to improve timely recognition and treatment for all patients experiencing irAEs.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Integrative Psychiatry Certificate Program | $3,350 |
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Adolescent Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Physical Medicine & Rehabilitation
- Practice Management & Ethics
- Primary Care Sports Medicine
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Rehabilitation
- Sports & Exercise Medicine
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1 credit
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedJan 14, 2026
-
Last day to claim creditJan 1, 2027 3 months left
-
Northeast Georgia Medical Center & Health System, Inc. IM Grand Rounds: Oncological Emergencies and Immune-Related Adverse Events (irAEs) A NCCN Guideline Approach
-
American Society of Health-System Pharmacists Checkpoint Well Taken: Identification and Management of Immune Related Adverse Events for Healthcare Practitioners
-
Learner’s Digest International (TM) Immune-Related Adverse Events of Checkpoint Inhibitors
